Per genes are mutated or deleted in many tumor tissues, and altered PER2 expression is common in human breast cancer (Chen et al. 2005; Winter et al. 2007) and in patients with prostate cancer (Kiss and Ghosh 2016). Here, PER2 is linked to breast carcinoma.